Lumera is planning to roll out its NanoCapture HPT protein array platform during the first quarter of 2006, according to a company official.

Hélène Jaillet, Lumera's director of investor relations, told BioArray News last week that the Bothell, Wash.-based company is getting closer to commercializing the array, developed with heterodimer protein technology licensed from Helix Biopharma. If Lumera launches the chip on schedule, it will be the second of its three core array technologies to hit the market.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.